Kristina Elizabeth Hawk, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 17
Offices
17 locations · Stanford Health Care · Kern Radiology Medical Group Inc · Regents of the University of California · Fresno Imaging Center · Desert Advanced Imaging Medical Center · Beverly Radiology Medical Group III
Hospitals listed: Imperial Valley Health - El Centro Hospital · Stanford Health Care · UC San Diego Health Hillcrest - Hillcrest Med Ctr. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hawk’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A125036 · Current
Licensed to practise in California · since 2013 · expires 2028-07-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Centro Regional Medical CenterEl Centro, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of El Centro Regional Medical CenterPatients rate it 2 of 5 · 54% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Clostridium Difficile (C.Diff): 2.46, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- UC San Diego Health Hillcrest - Hillcrest Med CtrSan Diego, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of Moores Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 105.39 (74.34 to 136.44) · 381 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.597, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.618, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.376, Oct 2024 – Sep 2025
See every measure and the patient survey for El Centro Regional Medical Center
Behind the star rating — Deaths: 0 better, 4 the same, 2 worse of 6 measures. Safety: 0 better, 3 the same, 1 worse of 4 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 2.46 | Worse | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.03) · 508 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.46 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.2 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.1 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18 · 309 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 155 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.5 · 951 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.03 to 0.48) · 2,448 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,578 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.16 (0.65 to 5.67) · 246 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 241 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.61 (0 to 18.37) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (1.7 to 10.23) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.21) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.28 (0 to 1.19) · 2,164 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 2.298 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 2.854 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 51.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 45.4 · 316 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 331 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.4) · 113 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.2 (6.7 to 12.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.2 to 16.8) · 181 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 158 cases | No different | Jan 2024 – Dec 2024 |
What patients said (273 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 54% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UC San Diego Health Hillcrest - Hillcrest Med Ctr
Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 105.39 (74.34 to 136.44) · 381 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.597 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.618 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.376 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0.11 to 1.54) · 3,862 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.84 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 510 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 696 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 435 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 5,739 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.32) · 12,387 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.44) · 13,596 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.59 (3.24 to 5.94) · 4,389 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.12) · 2,419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (1.23 to 3.29) · 4,116 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.93 (6.61 to 13.25) · 2,232 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.31 (5.24 to 9.38) · 2,410 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.32 (1.07 to 3.56) · 1,286 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.38 (0.02 to 0.75) · 11,838 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 181 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.672 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 302 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 891 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 216 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.9 · 620 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.7 · 946 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.8 to 7) · 1,507 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.3 (10.7 to 14) · 1,507 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.1 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.7 · 177 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.4 (8.5 to 13) · 4,116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1) · 2,130 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,680 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$103,760
Medicare paid this office $103,760 for 1,128 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study from skull base to mid-thigh with ct scan | 417 | $36,037 | $83 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 126 | $13,202 | $96 |
| Nuclear medicine study whole body with ct scan | 116 | $11,148 | $92 |
| Nuclear medicine study whole body with ct scan | 67 | $7,172 | $101 |
| Mri scan of brain before and after contrast | 68 | $5,955 | $88 |
See all 16 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 417 | $36,037 | $83 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 126 | $13,202 | $96 |
| Nuclear medicine study whole body with ct scan | 116 | $11,148 | $92 |
| Nuclear medicine study whole body with ct scan | 67 | $7,172 | $101 |
| Mri scan of brain before and after contrast | 68 | $5,955 | $88 |
| Ct scan head or brain without contrast | 127 | $4,161 | $31 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 15 | $4,120 | $275 |
| Mri scan of brain without contrast | 43 | $2,416 | $56 |
| Ct scan of blood vessels of head with contrast | 35 | $2,361 | $66 |
| Ct scan of blood vessels of neck with contrast | 35 | $2,267 | $63 |
| Ct scan of soft tissue of neck with contrast | 37 | $1,929 | $52 |
| Mri scan of lower spinal canal before and after contrast | 13 | $1,123 | $86 |
| Mri scan of lower spinal canal without contrast | 17 | $972 | $57 |
| Mri scan of upper spinal canal without contrast | 12 | $730 | $56 |
| Ct scan of face without contrast | 17 | $547 | $32 |
| Ct scan head or brain with contrast | 11 | $467 | $42 |
Who their Medicare patients are
1,128 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 13% · Women 49% · Also on Medicaid 28% · Health risk score 2.42. Sicker patients than 9 in 10 peers; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 74% · Cancer 47% · Chronic kidney disease 31% · Diabetes 30% · Coronary heart disease 30% · Depression 27% · Atrial fibrillation 23% · Heart failure 22% · Stroke 19% · COPD 18% · Dementia 11%.
The office billed $2,795,184, Medicare allowed $138,725 and paid $103,760; for 2,133 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,128 | 2,133 | 74 | 2.42 | $2,795,184 | $103,760 |
| 2023 | 848 | 922 | 74 | 2.35 | $1,901,296 | $82,275 |
| 2022 | 787 | 825 | 74 | 2.29 | $839,401 | $69,683 |
| 2021 | 1,127 | 1,197 | 74 | 2.30 | $529,332 | $63,623 |
| 2020 | 1,499 | 1,642 | 73 | 2.49 | $609,727 | $66,081 |
| 2019 | 1,609 | 1,873 | 72 | 2.38 | $664,752 | $78,356 |
| 2018 | 558 | 610 | 74 | 2.62 | $349,243 | $60,526 |
| 2017 | 330 | 438 | 78 | 3.20 | $44,319 | $10,504 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 563 | $55,327 | $89 |
| Nuclear medicine study whole body with ct scan | 139 | $12,690 | $88 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 84 | $8,540 | $97 |
| Nuclear medicine study whole body with ct scan | 41 | $4,232 | $96 |
| Nuclear medicine study of brain with metabolic evaluation | 11 | $571 | $52 |
2022: 6 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 391 | $39,237 | $96 |
| Nuclear medicine study whole body with ct scan | 107 | $10,873 | $98 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 104 | $9,902 | $92 |
| Nuclear medicine study whole body with ct scan | 44 | $4,806 | $102 |
| Ct scan head or brain without contrast | 29 | $832 | $29 |
| X-ray of chest, 1 view | 65 | $477 | $7 |
2021: 12 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 232 | $23,070 | $97 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 98 | $11,029 | $107 |
| Nuclear medicine study whole body with ct scan | 82 | $8,906 | $102 |
| Ct scan head or brain without contrast | 170 | $5,886 | $34 |
| Nuclear medicine study whole body with ct scan | 26 | $2,906 | $108 |
| X-ray of chest, 1 view | 337 | $2,521 | $7 |
| Ct scan of blood vessels of chest with contrast | 33 | $2,370 | $72 |
| Mri scan of brain without contrast | 23 | $1,295 | $56 |
| Limited ultrasound scan of abdomen | 17 | $414 | $24 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $353 | $19 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 12 | $257 | $21 |
| X-ray of chest, 2 views | 14 | $115 | $8 |
2020: 17 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 161 | $18,190 | $108 |
| Ct scan head or brain without contrast | 279 | $10,087 | $36 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 73 | $7,612 | $101 |
| Nuclear medicine study whole body with ct scan | 54 | $5,982 | $109 |
| X-ray of chest, 1 view | 587 | $4,683 | $8 |
| Mri scan of brain without contrast | 43 | $2,665 | $62 |
| Nuclear medicine study whole body with ct scan | 24 | $2,553 | $106 |
| Ct scan of blood vessels of chest with contrast | 21 | $1,679 | $80 |
| Ct scan of abdomen and pelvis without contrast | 20 | $1,370 | $68 |
| Ct scan of blood vessels of head with contrast | 15 | $1,367 | $76 |
| Ct scan of blood vessels of neck with contrast | 16 | $1,239 | $73 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 30 | $896 | $30 |
| Ct scan of upper spine without contrast | 18 | $789 | $44 |
| X-ray of chest, 2 views | 68 | $622 | $9 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $561 | $19 |
| Ct scan of chest without contrast | 11 | $559 | $51 |
| Limited ultrasound scan of abdomen | 13 | $332 | $26 |
2019: 21 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 209 | $22,845 | $103 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 94 | $10,178 | $102 |
| Nuclear medicine study whole body with ct scan | 75 | $8,975 | $104 |
| Ct scan head or brain without contrast | 197 | $7,112 | $36 |
| Nuclear medicine study whole body with ct scan | 35 | $4,041 | $99 |
| X-ray of chest, 1 view | 460 | $3,731 | $8 |
| Ct scan of abdomen and pelvis with contrast | 33 | $2,534 | $77 |
| Ct scan of abdomen and pelvis without contrast | 33 | $2,427 | $74 |
| Ct scan of blood vessels of chest with contrast | 24 | $1,834 | $76 |
| X-ray of chest, 2 views | 158 | $1,512 | $9 |
| Ct scan of upper spine without contrast | 21 | $952 | $45 |
| Mri scan of brain without contrast | 12 | $755 | $63 |
| Limited ultrasound scan of abdomen | 19 | $466 | $25 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $435 | $29 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $323 | $18 |
| X-ray of abdomen, 1 view | 34 | $281 | $8 |
| X-ray of abdomen, 2 views | 16 | $160 | $10 |
| X-ray of hip, 2-3 views | 15 | $153 | $10 |
| X-ray of knee, 3 views | 17 | $130 | $8 |
| X-ray of lower and sacral spine, 2-3 views | 13 | $124 | $10 |
| X-ray of hand, minimum of 3 views | 13 | $98 | $8 |
2018: 5 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 272 | $30,347 | $105 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 137 | $15,282 | $105 |
| Nuclear medicine study whole body with ct scan | 93 | $10,358 | $106 |
| Nuclear medicine study whole body with ct scan | 29 | $3,357 | $102 |
| X-ray of chest, 1 view | 16 | $94 | $6 |
2017: 4 services
| X-ray of chest, 1 view, front | 185 | $1,707 | $8 |
| Ct scan head or brain without contrast | 25 | $939 | $36 |
| Ct scan of abdomen and pelvis without contrast | 12 | $899 | $75 |
| X-ray of abdomen, single view | 18 | $141 | $8 |
Medicaid work
$160,817 in 2024
Medicaid paid $160,817 for 694 billed services this clinician did in 2024, up to 55 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 340 | $145,342 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 74 | $9,065 |
| Computed tomography, head or brain; without contrast material | 182 | $5,762 |
| MRI BRAIN BRAIN STEM W/O CONTRAST MATERIAL | 13 | $575 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 85 | $74 |
| 2024 | 694 | 5 | 55 | $160,817 |
| 2023 | 1,054 | 5 | 50 | $405,302 |
| 2022 | 195 | 1 | 34 | $45,683 |
| 2021 | 122 | 3 | 26 | $14,279 |
| 2020 | 584 | 4 | 49 | $10,867 |
| 2019 | 940 | 4 | 46 | $12,658 |
| 2018 | 139 | 2 | 28 | $24,080 |
See the largest Medicaid services in earlier years
2023
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 580 | $362,239 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 218 | $42,684 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 220 | $233 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19 | $136 |
| Puncture of skin for collection of blood sample | 17 | $8 |
2022
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 195 | $45,683 |
2021
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 81 | $10,584 |
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; whole body | 14 | $3,491 |
| Radiologic examination, chest; single view | 27 | $203 |
2020
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 46 | $6,286 |
| Radiologic examination, chest; single view | 408 | $2,247 |
| Computed tomography, head or brain; without contrast material | 102 | $2,140 |
| Radiologic examination, chest; 2 views | 28 | $193 |
2019
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 34 | $4,945 |
| Computed tomography, head or brain; without contrast material | 196 | $4,205 |
| Radiologic examination, chest; single view | 503 | $2,363 |
| Radiologic examination, chest; 2 views | 207 | $1,144 |
2018
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 123 | $24,060 |
| Radiologic examination, chest; single view | 16 | $20 |
Money from drug and device companies
$20,266 in 2025
| 2025 | 1 | 21 | $16,075 | $20,266 |
| 2024 | 1 | 9 | $13,150 | $14,607 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Blue Earth Diagnostics | Posluma | $20,266 | 21 payments
|
See all 21 published payments
| Blue Earth Diagnostics | Honoraria · 2025-12-18 | Posluma | $3,325 |
| Blue Earth Diagnostics | Honoraria · 2025-11-03 | Posluma | $3,250 |
| Blue Earth Diagnostics | Travel · 2025-11-03 | Posluma | $80 |
| Blue Earth Diagnostics | Travel · 2025-11-03 | Posluma | $858 |
| Blue Earth Diagnostics | Travel · 2025-11-03 | Posluma | $534 |
| Blue Earth Diagnostics | Meals · 2025-11-03 | Posluma | $100 |
| Blue Earth Diagnostics | Honoraria · 2025-08-01 | Posluma | $1,425 |
| Blue Earth Diagnostics | Travel · 2025-08-01 | Posluma | $597 |
| Blue Earth Diagnostics | Honoraria · 2025-08-01 | Posluma | $3,325 |
| Blue Earth Diagnostics | Honoraria · 2025-07-01 | Posluma | $2,850 |
| Blue Earth Diagnostics | Travel · 2025-06-19 | Posluma | $269 |
| Blue Earth Diagnostics | Travel · 2025-06-19 | Posluma | $243 |
| Blue Earth Diagnostics | Travel · 2025-06-19 | Posluma | $380 |
| Blue Earth Diagnostics | Travel · 2025-06-19 | Posluma | $80 |
| Blue Earth Diagnostics | Meals · 2025-06-19 | Posluma | $92 |
| Blue Earth Diagnostics | Travel · 2025-05-22 | Posluma | $238 |
| Blue Earth Diagnostics | Travel · 2025-05-22 | Posluma | $80 |
| Blue Earth Diagnostics | Travel · 2025-05-22 | Posluma | $520 |
| Blue Earth Diagnostics | Meals · 2025-05-22 | Posluma | $120 |
| Blue Earth Diagnostics | Honoraria · 2025-04-02 | Posluma | $475 |
| Blue Earth Diagnostics | Honoraria · 2025-04-02 | Posluma | $1,425 |
See earlier years (2024)
2024: $14,607
| Blue Earth Diagnostics | Posluma | $14,607 | 9 payments
|
Professional record
- NPI
- 1861784860
- Licence
- CA A125036California A125036: Current · expires 2028-07-31
- Group
- Stanford Health Care · Kern Radiology Medical Group Inc · Regents of the University of California · Fresno Imaging Center · Desert Advanced Imaging Medical Center · Beverly Radiology Medical Group III
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Diagnostic radiology (2085R0202X); Federal specialty code 207U00000X (207U00000X); Federal specialty code 2085N0904X (2085N0904X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-05-09
- NPI last updated
- 2026-02-10
- NPI record certified
- 2026-02-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 W Arbor Dr, San Diego, CA, 92103